Cibus Appoints Co-Founder Rory Riggs as Chief Executive Officer
type: NewsArticle

Cibus Closes Calyxt Deal
type: NewsArticle

Cibus Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
type: NewsArticle

Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer
type: NewsArticle

Cibus Opens Gene Editing Facility for Trait Production
type: NewsArticle

Margaret Crotty and Rory Riggs Health Care Leadership Award, 2024
type: NewsArticle

Regarding Cloe
type: NewsArticle

Royalty Pharma Co-Founder Writes Open Letter to Board of Elan Ahead of EGM
type: NewsArticle

Syntax LLC Announces Launch of Stratified LargeCap ESG Index
type: NewsArticle

Functional classification systems
type: DefinedTerm
description: Inventor of the coordinate-based Locus Model and Functional Information System for classifying economic activity by function rather than conventional industry category.
term code: thought leader

Index construction and portfolio classification
type: DefinedTerm
description: Built the Syntax Stratified Indices, benchmark indices constructed on functional rather than conventional sector classification.
term code: expert

Mergers and acquisitions
type: DefinedTerm
description: Managing Director in M&A at PaineWebber, 1981–1990.
term code: advanced

Pharmaceutical royalty finance
type: DefinedTerm
description: Founded and built Royalty Pharma into the world's largest acquirer of pharmaceutical royalties, helping create the category as an investable asset class.
term code: expert

Precision gene editing / agricultural biotechnology
type: DefinedTerm
description: Led Cibus's application of production-system methodology to plant biology through the Rapid Trait Development System.
term code: expert

Managing Member
type: Occupation
description: Managing Member of Balfour Venture Partners.

President, CFO, and Director
type: Occupation
description: President, CFO, and Director of BioMatrix, overseeing the launch of Synvisc, a viscosupplementation treatment.

occupation-biomatrix-inc-president-cfo-and-director-role
type: Role
end date: 2000
has occupation: President, CFO, and Director
role name: President, CFO, and Director at BioMatrix Inc.
start date: 1996

Chairman of the Board
type: Occupation
description: Transitioned from Chief Executive Officer to Chairman of the Board in June 2026 as Craig Wichner became CEO.

occupation-cibus-inc-chairman-of-the-board-role
type: Role
has occupation: Chairman of the Board
role name: Chairman of the Board at Cibus Inc.
start date: 2026-06

Chief Executive Officer
type: Occupation
description: Co-founder and CEO of Cibus, the leading precision gene-editing company for agriculture. Applied the Locus Model's functional-systems approach to plant biology through the Rapid Trait Development System (RTDS).

occupation-cibus-inc-chief-executive-officer-role
type: Role
end date: 2026-06
has occupation: Chief Executive Officer
role name: Chief Executive Officer at Cibus Inc.
start date: 2021-10-07

Chair
type: Occupation
description: Chair of eReceivables, a healthcare service technology company.

Chairman
type: Occupation
description: Chairman of Nucelis Inc.

Managing Director, Mergers & Acquisitions
type: Occupation
description: Managing Director in the mergers and acquisitions group at PaineWebber.

occupation-painewebber-inc-managing-director-mergers-acquisitions-role
type: Role
end date: 1990
has occupation: Managing Director, Mergers & Acquisitions
role name: Managing Director, Mergers & Acquisitions at PaineWebber Inc.
start date: 1981

Chief Executive Officer
type: Occupation
description: CEO of RF&P, a real estate investment company owned by the Virginia State Retirement System.
occupation location: Virginia, United States

Virginia, United States
type: Place

occupation-rfp-corporation-chief-executive-officer-role
type: Role
end date: 1995
has occupation: Chief Executive Officer
role name: Chief Executive Officer at RF&P Corporation
start date: 1991

Chairman and Founder
type: Occupation
description: Co-founded Royalty Pharma in 1996 with a $60 million start; built it into the world's largest acquirer of pharmaceutical royalties, holding partial royalty rights on seven of the top thirty drugs sold in the United States. Served as Chairman from 2003 and resigned as a director on June 6, 2024.

occupation-royalty-pharma-plc-chairman-and-founder-role
type: Role
end date: 2024-06-06
has occupation: Chairman and Founder
role name: Chairman and Founder at Royalty Pharma plc
start date: 1996

General Partner / Co-Founder
type: Occupation
description: General Partner and co-founder of Scientia Ventures.

Executive Chairman / Founder
type: Occupation
description: Founded Locus Analytics in 2009 as an economic research firm to pioneer Systems Economics and develop and patent the Functional Information System. Syntax and Locus Analytics merged in March 2023. Built the coordinate-based Locus Model and FIS information infrastructure for finance and economic data, and the Syntax Stratified Indices.

occupation-syntax-data-syntax-llc-locus-analytics-executive-chai-7ec1f0-role
type: Role
has occupation: Executive Chairman / Founder
role name: Executive Chairman / Founder at Syntax Data (Syntax LLC / Locus Analytics)
start date: 2009

CEO and Trustee
type: Occupation
description: CEO and Trustee of the Syntax-affiliated ETF trust since 2017.

occupation-webs-etf-trust-syntax-etf-trust-ceo-and-trustee-role
type: Role
has occupation: CEO and Trustee
role name: CEO and Trustee at WEBS ETF Trust (Syntax ETF Trust)
start date: 2017

Bond Street Marketplace
type: Organization

org-bond-street-marketplace-affiliation
type: OrganizationRole
affiliation: Bond Street Marketplace
description: Angel investor and board member of the fintech company Bond Street Marketplace.
role name: Angel Investor / Board Member

Feinstein Institute (Northwell Health)
type: Organization

org-feinstein-institute-northwell-health-affiliation
type: OrganizationRole
affiliation: Feinstein Institute (Northwell Health)
description: Director of the Feinstein Institute, the research arm of Northwell Health.
role name: Director

FibroGen Inc.
type: Organization

org-fibrogen-inc-affiliation
type: OrganizationRole
affiliation: FibroGen Inc.
description: Co-founder and director of FibroGen since October 1993 — his longest confirmed board tenure.
role name: Co-Founder and Director
start date: 1993-10

GeneNews / StageZero Life Sciences
type: Organization

org-genenews-stagezero-life-sciences-affiliation
type: OrganizationRole
affiliation: GeneNews / StageZero Life Sciences
description: Board Chair and director of GeneNews, later StageZero Life Sciences, since 1998.
role name: Board Chair / Director
start date: 1998

Intra-Cellular Therapies Inc.
type: Organization

org-intra-cellular-therapies-inc-affiliation
type: OrganizationRole
affiliation: Intra-Cellular Therapies Inc.
description: Director of Intra-Cellular Therapies from January 2014, serving on the Audit Committee.
end date: 2025
role name: Director, Audit Committee
start date: 2014-01

New York Genome Center
type: Organization

org-new-york-genome-center-affiliation
type: OrganizationRole
affiliation: New York Genome Center
description: Director of the New York Genome Center, his primary current nonprofit board.
role name: Board Member

Nuredis Inc.
type: Organization

org-nuredis-inc-affiliation
type: OrganizationRole
affiliation: Nuredis Inc.
description: Director of Nuredis Inc.
role name: Director

Rory Riggs
type: Organization

SUGEN Inc.
type: Organization

org-sugen-inc-affiliation
type: OrganizationRole
affiliation: SUGEN Inc.
description: Co-founder and board member of SUGEN.
role name: Co-Founder and Board Member

Syntax Data (Syntax LLC / Locus Analytics)
type: Organization

BioMatrix Inc.
type: Person
description: President, CFO, and Director, 1996–2000; oversaw the launch of Synvisc.

Cibus Inc.
type: Person
description: Co-founder; CEO 2021–2026, then Chairman of the Board.

Columbia University
type: Person
description: Graduate alma mater (MBA).

Feinstein Institute (Northwell Health)
type: Person
description: Current director of the research arm of Northwell Health.

FibroGen Inc.
type: Person
description: Co-founder and director since October 1993.

Intra-Cellular Therapies Inc.
type: Person
description: Director, 2014–2025.

Middlebury College
type: Person
description: Undergraduate alma mater (BA).

New York Genome Center
type: Person
description: Current director.

PaineWebber Inc.
type: Person
description: Managing Director, Mergers & Acquisitions, 1981–1990.

RF&P Corporation
type: Person
description: CEO, 1991–1995, a Virginia State Retirement System–owned real estate investment company.

Royalty Pharma plc
type: Person
description: Co-founder and Chairman (2003–2024); built the pharmaceutical royalty asset class.

Scientia Ventures LLC
type: Person
description: General Partner and co-founder.

SUGEN Inc.
type: Person
description: Co-founder and board member.

Syntax Data (Syntax LLC / Locus Analytics)
type: Person
description: Founder and Executive Chairman; built the Locus Model, Functional Information System, and Syntax Stratified Indices.

Rory Riggs
type: WebSite
description: The personal site of Rory Riggs — inventor of the Locus Model and Functional Coordinates, founder of Systems Economics, and Executive Chairman of Syntax Data. Documents his work across financial classification (FIS, Syntax Stratified Indices), agricultural biotechnology (Cibus, Rapid Trait Development System), and pharmaceutical royalties (Royalty Pharma).
language: en
publisher: Rory Riggs

Home
type: ListItem
item: https://theroryriggs.com
position: 1

About
type: ListItem
item: https://theroryriggs.com/about
position: 2

Credentials - Rory Riggs
type: ListItem
item: https://theroryriggs.com/credentials
position: 3

webpage-encoding-jsonld
type: MediaObject
encoding format: application/ld+json

webpage-encoding-n3
type: MediaObject
encoding format: text/n3

webpage-encoding-nq
type: MediaObject
encoding format: application/n-quads

webpage-encoding-nt
type: MediaObject
encoding format: application/n-triples

webpage-encoding-rdf
type: MediaObject
encoding format: application/rdf+xml

webpage-encoding-rj
type: MediaObject
encoding format: application/rdf+json

webpage-encoding-trig
type: MediaObject
encoding format: application/trig

webpage-encoding-trix
type: MediaObject
encoding format: application/xml

webpage-encoding-ttl
type: MediaObject
encoding format: text/turtle

BA
type: EducationalOccupationalCredential
credential category: degree
description: Undergraduate degree.
main entity of page: Credentials - Rory Riggs
recognized by: Middlebury College

MBA
type: EducationalOccupationalCredential
credential category: degree
description: Graduate business degree.
main entity of page: Credentials - Rory Riggs
recognized by: Columbia University

Columbia University
type: CollegeOrUniversity

Middlebury College
type: CollegeOrUniversity

Credentials - Rory Riggs
type: ProfilePage
about: Rory Riggs
breadcrumb: breadcrumb
encoding: webpage-encoding-jsonld
encoding: webpage-encoding-n3
encoding: webpage-encoding-nq
encoding: webpage-encoding-nt
encoding: webpage-encoding-rdf
encoding: webpage-encoding-rj
encoding: webpage-encoding-trig
encoding: webpage-encoding-trix
encoding: webpage-encoding-ttl
has part: BA
has part: MBA
language: en
is part of: Rory Riggs
main entity: Rory Riggs
publisher: Rory Riggs

Rory Riggs
type: Person
additional name: Balfour
affiliation: org-bond-street-marketplace-affiliation
affiliation: org-feinstein-institute-northwell-health-affiliation
affiliation: org-fibrogen-inc-affiliation
affiliation: org-genenews-stagezero-life-sciences-affiliation
affiliation: org-intra-cellular-therapies-inc-affiliation
affiliation: org-new-york-genome-center-affiliation
affiliation: org-nuredis-inc-affiliation
affiliation: org-sugen-inc-affiliation
alternate name: Rory B. Riggs
alternate name: Rory Balfour Riggs
alumni of: Columbia University
alumni of: Middlebury College
description: Rory Riggs is an inventor, executive, and investor who applies one system, the Locus Model, across biotechnology, finance, and economics. Mr. Riggs is Executive Chairman of Syntax Data, which has built a foundational coordinate-based information infrastructure for finance and economic data based on his patented Locus Model and Functional Information System (FIS).
disambiguating description: Rory Riggs is an inventor, executive, and investor who applies one system, the Locus Model, across biotechnology, finance, and economics.
family name: Riggs
gender: male
given name: Rory
has credential: BA
has credential: MBA
has occupation: Managing Member
has occupation: occupation-biomatrix-inc-president-cfo-and-director-role
has occupation: occupation-cibus-inc-chairman-of-the-board-role
has occupation: occupation-cibus-inc-chief-executive-officer-role
has occupation: Chair
has occupation: Chairman
has occupation: occupation-painewebber-inc-managing-director-mergers-acquisitions-role
has occupation: occupation-rfp-corporation-chief-executive-officer-role
has occupation: occupation-royalty-pharma-plc-chairman-and-founder-role
has occupation: General Partner / Co-Founder
has occupation: occupation-syntax-data-syntax-llc-locus-analytics-executive-chai-7ec1f0-role
has occupation: occupation-webs-etf-trust-syntax-etf-trust-ceo-and-trustee-role
job title: Executive Chairman / Founder
knows: BioMatrix Inc.
knows: Cibus Inc.
knows: Columbia University
knows: Feinstein Institute (Northwell Health)
knows: FibroGen Inc.
knows: Intra-Cellular Therapies Inc.
knows: Middlebury College
knows: New York Genome Center
knows: PaineWebber Inc.
knows: RF&P Corporation
knows: Royalty Pharma plc
knows: Scientia Ventures LLC
knows: SUGEN Inc.
knows: Syntax Data (Syntax LLC / Locus Analytics)
knows about: Functional classification systems
knows about: Index construction and portfolio classification
knows about: Mergers and acquisitions
knows about: Pharmaceutical royalty finance
knows about: Precision gene editing / agricultural biotechnology
knows language: English
subject of: Cibus Appoints Co-Founder Rory Riggs as Chief Executive Officer
subject of: Cibus Closes Calyxt Deal
subject of: Cibus Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
subject of: Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer
subject of: Cibus Opens Gene Editing Facility for Trait Production
subject of: Margaret Crotty and Rory Riggs Health Care Leadership Award, 2024
subject of: Regarding Cloe
subject of: Royalty Pharma Co-Founder Writes Open Letter to Board of Elan Ahead of EGM
subject of: Syntax LLC Announces Launch of Stratified LargeCap ESG Index
works for: Syntax Data (Syntax LLC / Locus Analytics)